Treatment of Spontaneous EAE by Laquinimod Reduces Tfh, B Cell Aggregates, and Disease Progression

Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000272
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Α4-Integrin Deficiency in B Cells Does Not Affect Disease in a T-Cell–mediated EAE Disease Model

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2019English

Dendritic Cell Status Modulates the Outcome of HIV-Related B Cell Disease Progression

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2011English

Treatment With IL-10 Producing B Cells in Combination With E2 Ameliorates EAE Severity and Decreases CNS Inflammation in B Cell-Deficient Mice

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2015English

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent TFH- B Cell Axis.

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Early Th1 Cell Differentiation Is Marked by a TFH Cell-Like Transition

Immunity
Infectious DiseasesAllergyImmunology
2011English

Editorial: Parkinson's Disease: Cell Vulnerability and Disease Progression

Frontiers in Neuroanatomy
AnatomyNeuroscienceCellularMolecular Neuroscience
2015English

Progression and Transformation of Clonally Heterogeneous B-Cell Lymphoma

PLoS ONE
Multidisciplinary
2015English

Pathogenic CD4+ T Cells Regulating B-Cell Differentiation in Autoimmunity: Not Exactly TFH Cells

Immunology and Cell Biology
AllergyImmunologyCell Biology
2017English

Author Correction: Laquinimod Treatment in the R6/2 Mouse Model

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy